Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of Venlafaxine hydrochloride

References

• Sweetman SC, Blake PS. (1999). Martindle’s: The Extra Pharmacopoeia. London Pharmaceutical Press, London.
   Google Scholar
• Aguiar MMGBd, Albuquerque RPd, Marinho DS, Braga BRS, Dornelas CB, Oliveira A, Sousa VPd, Torres SR, Alviano DS, Alviano CS, Cabral LM, Holandino C. (2010). Oral sustained release nystatIn tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. Drug Dev Ind Pharm, 36:594–600.
   PubMed Web of Science ®Google Scholar
• Hamza Yel-S, Aburahma MH. (2010). Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and In vitro investigations. Drug Dev Ind Pharm, 36:337–349.
   PubMed Web of Science ®Google Scholar
• Pajander J, Korhonen O, Laamanen M, Ryynänen EL, Grimsey I, van Veen B et al. (2009). Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets. J Pharm Sci, 98:3676–3690.
   PubMed Web of Science ®Google Scholar
• Quinten T, De Beer T, Almeida A, Vlassenbroeck J, Van Hoorebeke L, Remon JP et al. (2011). Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm, 37:149–159.
   PubMed Web of Science ®Google Scholar
• Roberts M, Vellucci D, Mostafa S, Miolane C, Marchaud D. (2011). Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. Drug Dev Ind Pharm, 1–9.
   Google Scholar
• Shah SN, Asghar S, Choudhry MA, Akash MS, ur Rehman N, Baksh S. (2009). Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev Ind Pharm, 35:1470–1478.
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Venkatesh Babu R, Nappinai A, Sivaramakrishnan G. (2011). In vitro and In vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet. Drug Dev Ind Pharm, 37:436–445.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed In solid matrices. J Pharm Sci, 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface and agitation. Ind Eng Chem, 23:923–931.
   Google Scholar
• Korsmeyer RW, Peppas, NA. (1981). Macromolecular and modeling aspects of swelling-controlled systems. In: Roseman TJ, Mansdorf, SZ (Ed.), Controlled Release Delivery Systems. Marcel Dekker, New York, pp. 77–90.
   Google Scholar
• Alderman DA. (1984). A review of cellulose ethers In hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr, 5:1–9.
   Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today, 3:198–204.
   PubMedGoogle Scholar
• Kanjickal DG, Lopina ST. (2004). Modeling of drug release from polymeric delivery systems–a review. Crit Rev Ther Drug Carrier Syst, 21:345–386.
   PubMed Web of Science ®Google Scholar
• Levina M, Rajabi-Siahboomi AR. (2004). The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci, 93:2746–2754.
   PubMed Web of Science ®Google Scholar
• Miller-Chou BA, Koenig JL. (2003). A review of polymer dissolution. Prog Polym Sci, 28:1223–1270.
   Web of Science ®Google Scholar
• Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR. (2012). The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets. Drug Dev Ind Pharm. April 27, 2012. (doi:10.3109/03639045.2012.681053).
   Web of Science ®Google Scholar
• Ranga Rao KV, Padmalatha Devi K. (1988). Swelling controlled-release systems: recent developments and applications. Int J Pharm, 48:1–13.
   Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Viridén A, Wittgren B, Andersson T, Larsson A. (2009). The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets. Eur J Pharm Sci, 36:392–400.
   PubMed Web of Science ®Google Scholar
• Makhija SN, Vavia PR. (2002). Once daily sustained release tablets of venlafaxine, a novel antidepressant. Eur J Pharm Biopharm, 54:9–15.
   PubMed Web of Science ®Google Scholar
• Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S et al. (2004). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm, 269:509–522.
   PubMed Web of Science ®Google Scholar
• Katikaneni PR, Upadrashta SM, Neau SH, Mitra AK. (1995). Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int J Pharm, 123:119–125.
   Web of Science ®Google Scholar
• El-Shanawany S. (1993). Sustained release of nitrofurantoIn from inert wax matrixes. J Control Release, 26:11–19.
   Web of Science ®Google Scholar
• Hamdani J, Moës AJ, Amighi K. (2003). Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm, 260:47–57.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Choe JS, Kim CK. (1998). Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. J Microencapsul, 15:775–787.
   PubMed Web of Science ®Google Scholar
• Wu PC, Tsai MJ, Huang YB, Chang JS, Tsai YH. (2002). In vitro and In vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices. Int J Pharm, 243:119–124.
   PubMed Web of Science ®Google Scholar